Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection

Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Euro surveillance : bulletin européen sur les maladies transmissibles 2021-09, Vol.26 (35)
Hauptverfasser: Harder, Thomas, Koch, Judith, Vygen-Bonnet, Sabine, Külper-Schiek, Wiebe, Pilic, Antonia, Reda, Sarah, Scholz, Stefan, Wichmann, Ole
Format: Artikel
Sprache:eng
Schlagworte:
Letter
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 35
container_start_page
container_title Euro surveillance : bulletin européen sur les maladies transmissibles
container_volume 26
creator Harder, Thomas
Koch, Judith
Vygen-Bonnet, Sabine
Külper-Schiek, Wiebe
Pilic, Antonia
Reda, Sarah
Scholz, Stefan
Wichmann, Ole
description
doi_str_mv 10.2807/1560-7917.ES.2021.26.35.2100832
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8414955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2569384518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-4ea38424444d409eaab8502e0b9e1452297d508ed391b2a1bd506f2a7fb04bb3</originalsourceid><addsrcrecordid>eNptkc1u1DAQxy0Eoh_wDr7BJak_k7gH0Gq7hUpFldiqV2viTFqjjb3E3pX2xitw7OvxJGTpqgIJX8Yz85__jPQj5B1npWhYfcZ1xYra8LpcLEvBBC9FVUpdCs5YI8ULcvysePnX_4icpPSNMSWZEa_JkVSqrpnmx-TnbJMf4ph-_XikI6Z1DAnP6aLvvQO3oxA6in2PLvstBkyJxp7Ob-6uLgpu6Bac81OVwj34kDJdzr4ui3m8KwT14c9UDOf0SxyRdpCBxkAh7YZ1jgNk7_6rf0Ne9bBK-PYQT8nt5eJ2_rm4vvl0NZ9dF07qKhcKQTZKqOl1ihkEaBvNBLLWIFdaCFN3mjXYScNbAbydsqoXUPctU20rT8mHJ9v1ph2wcxjyCCu7Hv0A485G8PbfTvAP9j5ubaO4MlpPBu8PBmP8vsGU7eCTw9UKAsZNskJXZrpQ82aSfnySujGmNGL_vIYzu-dq96TsnpRdLO2eqxWVldoeuMrfDPWXcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2569384518</pqid></control><display><type>article</type><title>Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Harder, Thomas ; Koch, Judith ; Vygen-Bonnet, Sabine ; Külper-Schiek, Wiebe ; Pilic, Antonia ; Reda, Sarah ; Scholz, Stefan ; Wichmann, Ole</creator><creatorcontrib>Harder, Thomas ; Koch, Judith ; Vygen-Bonnet, Sabine ; Külper-Schiek, Wiebe ; Pilic, Antonia ; Reda, Sarah ; Scholz, Stefan ; Wichmann, Ole</creatorcontrib><identifier>ISSN: 1560-7917</identifier><identifier>ISSN: 1025-496X</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/1560-7917.ES.2021.26.35.2100832</identifier><identifier>PMID: 34477051</identifier><language>eng</language><publisher>European Centre for Disease Prevention and Control (ECDC)</publisher><subject>Letter</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-09, Vol.26 (35)</ispartof><rights>This article is copyright of the authors or their affiliated institutions, 2021. 2021 The authors or their affiliated institutions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c356t-4ea38424444d409eaab8502e0b9e1452297d508ed391b2a1bd506f2a7fb04bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414955/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414955/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids></links><search><creatorcontrib>Harder, Thomas</creatorcontrib><creatorcontrib>Koch, Judith</creatorcontrib><creatorcontrib>Vygen-Bonnet, Sabine</creatorcontrib><creatorcontrib>Külper-Schiek, Wiebe</creatorcontrib><creatorcontrib>Pilic, Antonia</creatorcontrib><creatorcontrib>Reda, Sarah</creatorcontrib><creatorcontrib>Scholz, Stefan</creatorcontrib><creatorcontrib>Wichmann, Ole</creatorcontrib><title>Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><subject>Letter</subject><issn>1560-7917</issn><issn>1025-496X</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptkc1u1DAQxy0Eoh_wDr7BJak_k7gH0Gq7hUpFldiqV2viTFqjjb3E3pX2xitw7OvxJGTpqgIJX8Yz85__jPQj5B1npWhYfcZ1xYra8LpcLEvBBC9FVUpdCs5YI8ULcvysePnX_4icpPSNMSWZEa_JkVSqrpnmx-TnbJMf4ph-_XikI6Z1DAnP6aLvvQO3oxA6in2PLvstBkyJxp7Ob-6uLgpu6Bac81OVwj34kDJdzr4ui3m8KwT14c9UDOf0SxyRdpCBxkAh7YZ1jgNk7_6rf0Ne9bBK-PYQT8nt5eJ2_rm4vvl0NZ9dF07qKhcKQTZKqOl1ihkEaBvNBLLWIFdaCFN3mjXYScNbAbydsqoXUPctU20rT8mHJ9v1ph2wcxjyCCu7Hv0A485G8PbfTvAP9j5ubaO4MlpPBu8PBmP8vsGU7eCTw9UKAsZNskJXZrpQ82aSfnySujGmNGL_vIYzu-dq96TsnpRdLO2eqxWVldoeuMrfDPWXcA</recordid><startdate>20210902</startdate><enddate>20210902</enddate><creator>Harder, Thomas</creator><creator>Koch, Judith</creator><creator>Vygen-Bonnet, Sabine</creator><creator>Külper-Schiek, Wiebe</creator><creator>Pilic, Antonia</creator><creator>Reda, Sarah</creator><creator>Scholz, Stefan</creator><creator>Wichmann, Ole</creator><general>European Centre for Disease Prevention and Control (ECDC)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210902</creationdate><title>Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection</title><author>Harder, Thomas ; Koch, Judith ; Vygen-Bonnet, Sabine ; Külper-Schiek, Wiebe ; Pilic, Antonia ; Reda, Sarah ; Scholz, Stefan ; Wichmann, Ole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-4ea38424444d409eaab8502e0b9e1452297d508ed391b2a1bd506f2a7fb04bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harder, Thomas</creatorcontrib><creatorcontrib>Koch, Judith</creatorcontrib><creatorcontrib>Vygen-Bonnet, Sabine</creatorcontrib><creatorcontrib>Külper-Schiek, Wiebe</creatorcontrib><creatorcontrib>Pilic, Antonia</creatorcontrib><creatorcontrib>Reda, Sarah</creatorcontrib><creatorcontrib>Scholz, Stefan</creatorcontrib><creatorcontrib>Wichmann, Ole</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harder, Thomas</au><au>Koch, Judith</au><au>Vygen-Bonnet, Sabine</au><au>Külper-Schiek, Wiebe</au><au>Pilic, Antonia</au><au>Reda, Sarah</au><au>Scholz, Stefan</au><au>Wichmann, Ole</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><date>2021-09-02</date><risdate>2021</risdate><volume>26</volume><issue>35</issue><issn>1560-7917</issn><issn>1025-496X</issn><eissn>1560-7917</eissn><pub>European Centre for Disease Prevention and Control (ECDC)</pub><pmid>34477051</pmid><doi>10.2807/1560-7917.ES.2021.26.35.2100832</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1560-7917
ispartof Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-09, Vol.26 (35)
issn 1560-7917
1025-496X
1560-7917
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8414955
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Letter
title Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Authors%E2%80%99%20response:%20Efficacy%20and%20effectiveness%20of%20COVID-19%20vaccines%20against%20SARS-CoV-2%20infection:%20More%20data%20on%20asymptomatic%20SARS-CoV-2%20infection&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Harder,%20Thomas&rft.date=2021-09-02&rft.volume=26&rft.issue=35&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/1560-7917.ES.2021.26.35.2100832&rft_dat=%3Cproquest_pubme%3E2569384518%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2569384518&rft_id=info:pmid/34477051&rfr_iscdi=true